5R01AG062588-04 |
2022 |
$807369 |
Elucidating clinical heterogeneity in early-onset AD via genomics, transcriptomics, and neuroimaging |
5R01AG062588-03 |
2021 |
$807369 |
Elucidating clinical heterogeneity in early-onset AD via genomics, transcriptomics, and neuroimaging |
5R01AG062588-02 |
2020 |
$806995 |
Elucidating clinical heterogeneity in early-onset AD via genomics; transcriptomics; and neuroimaging |
1R01AG062588-01 |
2019 |
$794566 |
Elucidating clinical heterogeneity in early-onset AD via genomics; transcriptomics; and neuroimaging |